Latest Shareholder Value News

QPM Energy Limited has successfully raised $10 million through an oversubscribed placement and launched a $2 million Share Purchase Plan to fast-track the 112MW Isaac Power Station, the cornerstone of its Isaac Energy Hub.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

Sarama Resources has raised A$2.7 million through a well-supported equity placement to fund a maiden drilling campaign in Western Australia's Laverton Gold District and advance its arbitration claim against Burkina Faso.

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

Noble Helium has arranged a $200,000 unsecured loan from its Non-Executive Chair as a short-term refinancing measure, aiming to bolster working capital without diluting shareholders. The company plans a webinar to outline its refinancing and strategic direction.

Butn Limited has locked in a $10 million corporate credit facility with Mighty Partners, providing non-dilutive capital to support its expanding receivables book and operational growth.

Gumtree Australia Markets Limited has agreed to sell its Capital Markets Business to ADVFN Limited for $6.8 million, streamlining its focus and reducing debt significantly.

Antipa Minerals reports significant new high-grade gold-copper mineralisation at its Minyari Gold-Copper Project in Western Australia, with early assay results confirming resource growth and new discoveries.

GBM Resources has completed the first tranche of its capital raising, issuing nearly 245 million shares at $0.006 each, while the second tranche and additional securities await shareholder approval.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.